For research use only. Not for therapeutic Use.
Artemether-d3 (CAS: 93787-85-0), a high-quality pharmaceutical research compound designed for advanced antimalarial and pharmacokinetic studies. As a deuterated analog of Artemether, it offers enhanced stability and improved pharmacokinetic properties. Artemether-d3 is ideal for use in pharmacological and biochemical research, providing precise and reliable data for your studies. This high-purity compound ensures consistent results, aiding in the development of novel therapies for malaria. Trusted by leading laboratories, Artemether-d3 is your go-to solution for cutting-edge antimalarial research. Unlock new possibilities in malaria treatment with Artemether-d3, where innovation meets reliability.
| Catalog Number | S000161 |
| CAS Number | 93787-85-0 |
| Molecular Formula | C16H23D3O5 |
| Purity | ≥95% |
| IUPAC Name | (1R,4S,5R,8S,9R,10S,12R,13R)-1,5,9-trimethyl-10-(trideuteriomethoxy)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane |
| InChI | InChI=1S/C16H26O5/c1-9-5-6-12-10(2)13(17-4)18-14-16(12)11(9)7-8-15(3,19-14)20-21-16/h9-14H,5-8H2,1-4H3/t9-,10-,11+,12+,13+,14-,15-,16-/m1/s1/i4D3 |
| InChIKey | SXYIRMFQILZOAM-SAMIBWLCSA-N |
| SMILES | [2H]C([2H])([2H])O[C@@H]1[C@@H]([C@@H]2CC[C@H]([C@H]3[C@]24[C@H](O1)O[C@@](CC3)(OO4)C)C)C |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Xiao, S., et al., Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop, 2002. 82(2): p. 175-81. [3]. Wu, Z.P., et al., Inhibitive effect of artemether on tumor growth and angiogenesis in the rat C6 orthotopic brain gliomas model. Integr Cancer Ther, 2009. 8(1): p. 88-92. |
